XTX Topco Ltd Buys 257,641 Shares of Tilray Inc (NASDAQ:TLRY)

XTX Topco Ltd boosted its position in shares of Tilray Inc (NASDAQ:TLRY) by 1,079.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 281,504 shares of the company’s stock after acquiring an additional 257,641 shares during the period. XTX Topco Ltd’s holdings in Tilray were worth $495,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in TLRY. Ferguson Wellman Capital Management Inc. purchased a new position in shares of Tilray in the third quarter valued at about $26,000. Signature Estate & Investment Advisors LLC purchased a new position in Tilray in the 2nd quarter worth approximately $29,000. Jeppson Wealth Management LLC bought a new position in Tilray in the 2nd quarter worth approximately $33,000. Vanguard Capital Wealth Advisors purchased a new stake in Tilray during the 2nd quarter valued at approximately $34,000. Finally, Pallas Capital Advisors LLC bought a new stake in shares of Tilray during the second quarter valued at approximately $37,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Price Performance

Shares of Tilray stock opened at $1.19 on Friday. The stock has a 50 day moving average of $1.48 and a 200 day moving average of $1.67. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. Tilray Inc has a 12 month low of $1.15 and a 12 month high of $2.97.

Tilray (NASDAQ:TLRY) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The firm had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.10) EPS. As a group, equities analysts expect that Tilray Inc will post -0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Roth Mkm dropped their target price on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research report on Friday, October 11th.

Insider Transactions at Tilray

In related news, CFO Carl A. Merton acquired 26,000 shares of the stock in a transaction dated Friday, November 15th. The stock was acquired at an average cost of $1.36 per share, with a total value of $35,360.00. Following the purchase, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at approximately $35,360. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.87% of the company’s stock.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.